Literature DB >> 10657614

Functional maturation of adult mouse resting microglia into an APC is promoted by granulocyte-macrophage colony-stimulating factor and interaction with Th1 cells.

F Aloisi1, R De Simone, S Columba-Cabezas, G Penna, L Adorini.   

Abstract

A precise knowledge of the early events inducing maturation of resting microglia into a competent APC may help to understand the involvement of this cell type in the development of CNS immunopathology. To elucidate whether signals from preactivated T cells are sufficient to induce APC features in resting microglia, microglia from the adult BALB/c mouse CNS were cocultured with Th1 and Th2 lines from DO11.10 TCR transgenic mice to examine modulation of APC-related molecules and Ag-presenting capacity. Upon Ag-specific interaction with Th1, but not Th2, cells, microglia strongly up-regulated the surface expression of MHC class II, CD40, and CD54 molecules. Induction of CD86 on mouse microglia did not require T cell-derived signals. Acutely isolated adult microglia stimulated Th1 cells to secrete IFN-gamma and, to a lesser extent, IL-2, but were inefficient stimulators of IL-4 secretion by Th2 cells. Microglia exposed in vitro to IFN-gamma showed enhanced expression of MHC class II, CD40, and CD54 molecules and became able to restimulate Th2 cells. In addition to IFN-gamma, GM-CSF increased the ability of microglia to activate Th1, but not Th2, cells without up-regulating MHC class II, CD40, or CD54 molecules. These results suggest that interaction with Th1 cells and/or Th1-secreted soluble factors induces the functional maturation of adult mouse microglia into an APC able to sustain CD4+ T cell activation. Moreover, GM-CSF, a cytokine secreted by T cells as well as reactive astrocytes, could prime microglia for Th1-stimulating capacity, possibly by enhancing their responsiveness to Th1-derived signals.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10657614     DOI: 10.4049/jimmunol.164.4.1705

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

1.  Role of viral persistence in retaining CD8(+) T cells within the central nervous system.

Authors:  N W Marten; S A Stohlman; C C Bergmann
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS.

Authors:  Bing Liao; Weihua Zhao; David R Beers; Jenny S Henkel; Stanley H Appel
Journal:  Exp Neurol       Date:  2012-06-23       Impact factor: 5.330

Review 3.  The myeloid cells of the central nervous system parenchyma.

Authors:  Richard M Ransohoff; Astrid E Cardona
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

4.  Microglia repetitively isolated from in vitro mixed glial cultures retain their initial phenotype.

Authors:  A M Floden; C K Combs
Journal:  J Neurosci Methods       Date:  2007-05-03       Impact factor: 2.390

Review 5.  The impact of neuroimmune changes on development of amyloid pathology; relevance to Alzheimer's disease.

Authors:  Marina A Lynch
Journal:  Immunology       Date:  2014-03       Impact factor: 7.397

Review 6.  The multifaceted profile of activated microglia.

Authors:  Marina A Lynch
Journal:  Mol Neurobiol       Date:  2009-07-23       Impact factor: 5.590

7.  A GMCSF-neuroantigen fusion protein is a potent tolerogen in experimental autoimmune encephalomyelitis (EAE) that is associated with efficient targeting of neuroantigen to APC.

Authors:  J Lori Blanchfield; Mark D Mannie
Journal:  J Leukoc Biol       Date:  2010-03       Impact factor: 4.962

8.  Subventricular zone microglia possess a unique capacity for massive in vitro expansion.

Authors:  Gregory P Marshall; Meryem Demir; Dennis A Steindler; Eric D Laywell
Journal:  Glia       Date:  2008-12       Impact factor: 7.452

9.  SOLUBLE CD40 LIGAND IN DEMENTIA.

Authors:  B Giunta; K P Figueroa; T Town; J Tan
Journal:  Drugs Future       Date:  2009-04-01       Impact factor: 0.148

10.  Acute in vivo exposure to interferon-gamma enables resident brain dendritic cells to become effective antigen presenting cells.

Authors:  Andres Gottfried-Blackmore; Ulrike W Kaunzner; Juliana Idoyaga; Jennifer C Felger; Bruce S McEwen; Karen Bulloch
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.